We serve Chemical Name:1-Dodecylnaphthalene CAS:38641-16-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Dodecylnaphthalene
CAS.NO:38641-16-6
Synonyms:Naphthalene, 1-dodecyl-;1-Dodecylnaphthalene;EINECS 254-054-7;Naphthalene, dodecyl-;1-N-DODECYLNAPHTHALENE
Molecular Formula:C22H32
Molecular Weight:296.490
HS Code:2902909090
Physical and Chemical Properties:
Melting point:30ºC
Boiling point:416.8±8.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.534
PSA:
Exact Mass:296.250397
LogP:9.75
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Naphthalene, 1-dodecyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-N-DODECYLNAPHTHALENE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 254-054-7 Use and application,1-N-DODECYLNAPHTHALENE technical grade,usp/ep/jp grade.
Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 1-Dodecylnaphthalene manufacturer Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 1-Dodecylnaphthalene supplier Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 1-Dodecylnaphthalene vendor Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. 1-Dodecylnaphthalene factory ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.��
